🇺🇸 FDA
Patent

US 12226450

Peptides and methods for treating disease

granted A61KA61K38/08A61K38/10

Quick answer

US patent 12226450 (Peptides and methods for treating disease) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/08, A61K38/10, A61K38/1793, A61P